{
  "citations": [],
  "guideline": {
    "objCls": "Guideline Annotation",
    "id": "PA166265221",
    "name": "Annotation of DPWG Guideline for olanzapine and CYP1A2",
    "alternateDrugAvailable": false,
    "cancerGenome": false,
    "crossReferences": [],
    "dosingInformation": false,
    "guidelineGenes": [],
    "hasTestingInfo": false,
    "history": [
      {
        "id": 1451697982,
        "date": "2022-02-28T00:00:00-08:00",
        "type": "Create",
        "version": 1
      },
      {
        "id": 1451704267,
        "date": "2022-03-03T16:33:37.260-08:00",
        "description": "Annotation current with May 2021 DPWG Guideline release",
        "type": "Note",
        "version": 0
      },
      {
        "id": 1451732906,
        "date": "2022-03-28T09:57:50.908-07:00",
        "description": "Annotation current with February 2022 DPWG guideline release",
        "type": "Note",
        "version": 0
      },
      {
        "id": 1451884460,
        "date": "2022-09-16T10:59:08.716-07:00",
        "description": "Fixed link to gene information document and added explanatory note",
        "type": "Update",
        "version": 0
      }
    ],
    "literature": [],
    "pediatric": false,
    "recommendation": false,
    "relatedAlleles": [],
    "relatedChemicals": [
      {
        "objCls": "Chemical",
        "id": "PA450688",
        "name": "olanzapine",
        "version": 6
      }
    ],
    "relatedGenes": [
      {
        "objCls": "Gene",
        "id": "PA27093",
        "symbol": "CYP1A2",
        "name": "cytochrome P450 family 1 subfamily A member 2",
        "version": 6459
      }
    ],
    "source": "DPWG",
    "summaryMarkdown": {
      "id": 1451697980,
      "html": "<p>There are currently no recommendations for olanzapine dosing based on CYP1A2 genotypes.</p>\n",
      "version": 0
    },
    "terms": [],
    "textMarkdown": {
      "id": 1451697981,
      "html": "<h3 id=\"may-2021-guideline\">May 2021 Guideline</h3>\n<p><em><strong>IMPORTANT: As of March 2022, gene information documents from the DPWG are no longer publicly available from the KNMP website. PharmGKB is currently providing PDF versions of these documents to users. These files were downloaded in February 2022. As such, we cannot guarantee that these documents match the mappings DPWG may use internally as there have been no publicly accessible updates since February 2022.</strong></em></p>\n<p>The Royal Dutch Pharmacists Association - Pharmacogenetics Working Group has evaluated therapeutic dose recommendations for olanzapine based on CYP1A2 genotypes. They conclude that this is NOT a gene-drug interaction, (see <a download=\"DPWG_May_2021.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/DPWG_May_2021.pdf\">Dutch guidelines May 2021 update</a>).</p>\n<p><a rel=\"noopener noreferrer\" href=\"https://www.g-standaard.nl/risicoanalyse/B0004647.PDF\" target=\"_blank\">Read for more information about this recommendation</a>, <a download=\"CYP1A2.pdf\" href=\"https://api.pharmgkb.org/v1/download/file/attachment/CYP1A2.pdf\">Read about gene information from DPWG</a></p>\n",
      "version": 1
    },
    "userId": "katrin",
    "version": 4
  }
}